Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nemaura Medical Inc. - Common Stock (NQ:NMRD)

0.1053 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nemaura Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.41% to 34,088.68 while the NASDAQ rose 1.27% to 11,659.16. The S&P 500... 
Via Benzinga
News headline image
Nemaura Medical's Program Shows Weight Loss In 100% Of Participants ↗
 
Via Benzinga
News headline image
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Jumps 100 Points; Crude Oil Down 1% ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.29% to 34,047.95 while the NASDAQ rose 0.88% to 11,613.37. The S&P... 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Why Nemaura Medical Stock Is Getting Hammered ↗
Nemaura Medical Inc (NASDAQ: NMRD) shares are trading lower by 38.8% to $1.75 Friday morning after the company announced pricing of a roughly $8.4 million registered direct offering and concurrent... 
Via Benzinga
News headline image
US Stocks Higher; Dow Rises 150 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.47% to 34,107.87 while the NASDAQ rose 0.55% to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million. 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces $500K PO from U.S. Health Provider HealthFleet
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nasdaq Surges 100 Points; Tesla Beats Q4 Views ↗
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 33,824.53 while the NASDAQ rose... 
Via Benzinga
News headline image
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
From Nemaura Medical, Inc.
Via Business Wire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
From Nemaura Medical, Inc.
Via Business Wire
News headline image
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Sidoti & Co. Micro Cap Conference
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Planet MicroCap Showcase: Virtual 2022
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
From Nemaura Medical, Inc
Via GlobeNewswire
InvestorNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Pilot Program Kicks Off in UK
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
From Nemaura Medical, Inc
Via GlobeNewswire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Fiscal Q2 2023 Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update
From Nemaura Medical, Inc
Via GlobeNewswire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Bernstein 2nd Annual CGM Disruptors Conference
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference
From Nemaura Medical, Inc
Via GlobeNewswire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Be Featured on the RedChip Money Report(R)
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.